These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19301972)

  • 1. Assessing the microlesion effect of subthalamic deep brain stimulation surgery with FDG PET.
    Pourfar M; Tang C; Lin T; Dhawan V; Kaplitt MG; Eidelberg D
    J Neurosurg; 2009 Jun; 110(6):1278-82. PubMed ID: 19301972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STN-DBS activates the target area in Parkinson disease: an FDG-PET study.
    Hilker R; Voges J; Weber T; Kracht LW; Roggendorf J; Baudrexel S; Hoevels M; Sturm V; Heiss WD
    Neurology; 2008 Sep; 71(10):708-13. PubMed ID: 18650492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease.
    Hilker R; Voges J; Weisenbach S; Kalbe E; Burghaus L; Ghaemi M; Lehrke R; Koulousakis A; Herholz K; Sturm V; Heiss WD
    J Cereb Blood Flow Metab; 2004 Jan; 24(1):7-16. PubMed ID: 14688612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving metabolic changes during the first postoperative year after subthalamotomy.
    Trost M; Su PC; Barnes A; Su SL; Yen RF; Tseng HM; Ma Y; Eidelberg D
    J Neurosurg; 2003 Nov; 99(5):872-8. PubMed ID: 14609167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified Fluorodeoxyglucose Metabolism in Motor Circuitry by Subthalamic Deep Brain Stimulation.
    Cao C; Zhang H; Li D; Zhan S; Zhang J; Zhang X; Zuo C; Sun B
    Stereotact Funct Neurosurg; 2017; 95(2):93-101. PubMed ID: 28259880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease.
    Kalbe E; Voges J; Weber T; Haarer M; Baudrexel S; Klein JC; Kessler J; Sturm V; Heiss WD; Hilker R
    Neurology; 2009 Jan; 72(1):42-9. PubMed ID: 19122029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
    Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
    J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic correlates of subthalamic nucleus activity in Parkinson's disease.
    Lin TP; Carbon M; Tang C; Mogilner AY; Sterio D; Beric A; Dhawan V; Eidelberg D
    Brain; 2008 May; 131(Pt 5):1373-80. PubMed ID: 18400841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus.
    Mirzadeh Z; Chapple K; Lambert M; Evidente VG; Mahant P; Ospina MC; Samanta J; Moguel-Cobos G; Salins N; Lieberman A; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2016 Apr; 124(4):902-7. PubMed ID: 26452116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alleviation of off-period dystonia in Parkinson disease by a microlesion following subthalamic implantation.
    Derrey S; Lefaucheur R; Chastan N; Gérardin E; Hannequin D; Desbordes M; Maltête D
    J Neurosurg; 2010 Jun; 112(6):1263-6. PubMed ID: 19877801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG-PET study of the bilateral subthalamic nucleus stimulation effects on the regional cerebral metabolism in advanced Parkinson disease.
    Li D; Zuo C; Guan Y; Zhao Y; Shen J; Zan S; Sun B
    Acta Neurochir Suppl; 2006; 99():51-4. PubMed ID: 17370764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects.
    Mure H; Hirano S; Tang CC; Isaias IU; Antonini A; Ma Y; Dhawan V; Eidelberg D
    Neuroimage; 2011 Jan; 54(2):1244-53. PubMed ID: 20851193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in brain glucose metabolism in subthalamic nucleus deep brain stimulation for advanced Parkinson's disease.
    Volonté MA; Garibotto V; Spagnolo F; Panzacchi A; Picozzi P; Franzin A; Giovannini E; Leocani L; Cursi M; Comi G; Perani D
    Parkinsonism Relat Disord; 2012 Jul; 18(6):770-4. PubMed ID: 22591577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic stimulation for Parkinson disease: determination of electrode location necessary for clinical efficacy.
    McClelland S; Ford B; Senatus PB; Winfield LM; Du YE; Pullman SL; Yu Q; Frucht SJ; McKhann GM; Goodman RR
    Neurosurg Focus; 2005 Nov; 19(5):E12. PubMed ID: 16398462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in Parkinson disease by subthalamic nucleus stimulation based on electrode placement: effects of reimplantation.
    Anheim M; Batir A; Fraix V; Silem M; Chabardès S; Seigneuret E; Krack P; Benabid AL; Pollak P
    Arch Neurol; 2008 May; 65(5):612-6. PubMed ID: 18474736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline in verbal fluency after subthalamic nucleus deep brain stimulation in Parkinson's disease: a microlesion effect of the electrode trajectory?
    Le Goff F; Derrey S; Lefaucheur R; Borden A; Fetter D; Jan M; Wallon D; Maltête D
    J Parkinsons Dis; 2015; 5(1):95-104. PubMed ID: 25374271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain networks underlying the clinical effects of long-term subthalamic stimulation for Parkinson's disease: a 4-year follow-up study with rCBF SPECT.
    Sestini S; Ramat S; Formiconi AR; Ammannati F; Sorbi S; Pupi A
    J Nucl Med; 2005 Sep; 46(9):1444-54. PubMed ID: 16157526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single electrode and multiple electrode guided electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Temel Y; Wilbrink P; Duits A; Boon P; Tromp S; Ackermans L; van Kranen-Mastenbroek V; Weber W; Visser-Vandewalle V
    Neurosurgery; 2007 Nov; 61(5 Suppl 2):346-55; discussion 355-7. PubMed ID: 18091250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.